Navigation Links
Oral Medicine Found To Remove Excess Iron in the Body

People suffering from severe chronic anemias and those with beta-thalassemia need frequent blood transfusions to remain healthy. // But the problem they frequently encounter is that due to transfusions there is an increase in the iron content in the body. This results in heart and liver failure.

The traditional treatment to remove excess iron is a time consuming process. Hence researchers studied deferasirox which is a new drug to treat patients suffering from chronic iron overload. The results of the study would be published in the month of May in the journal Blood. As of now the therapy to remove excess iron from the body is deferoxamine. This is administered for as long as the patient continues to receive blood transfusions, which, for many patients, can be for the rest of their lives. But the drug is very effective and safe.

The only drawback is that the drug has to be delivered by slow subcutaneous or intravenous infusion for eight to 12 hours a night over a period of five to seven days. On the other hand deferasirox is available in a once-daily, drinkable format, providing a promising alternative. Maria Domenica Cappellini, MD, of the University of Milan, Italy, and lead study author said that this reduces the strain on those patients especially children who require frequent blood transfusions help them to lead a normal and healthy life. She and her colleagues compared the efficacy and safety of the two drugs. Both children and adults participated in the study were diagnosed with chronic iron overload. People with beta-thalassemia, an inherited blood disorder, were selected for this study because complications of chronic iron overload have been best studied in those with this disease.

All participants continued receiving regular blood transfusions to treat beta-thalassemia throughout the year-long study. Participants were divided into two groups. In one group 290 patients received deferoxamine infusions five days a week and in t he second group 296 patients drank deferasirox dissolved in water each day before breakfast. Drug dosages were determined by each patient's liver iron concentration (LIC) level. The primary goal of the trial was to reduce LIC levels in those with high values and maintain LIC levels in those with low values. In the end of the study Deferasirox proved to be equally as effective as deferoxamine in patients receiving the highest doses of the drug. Deferasirox was generally well-tolerated with mild and common side effects such as skin rash and gastrointestional problems (abdominal pain, vomiting, diarrhea, and constipation).


Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Prince Charles lends support to Alternative Medicine
3. Healthy Medicine Or Harmful Intoxicant?
4. Medicines on the move
5. A surge in Lifestyle Medicine
6. Does Your Prescription Have An Inappropriate Medicine?
7. The Use Of Alternative Medicine On The Rise
8. New Medicine For Parkinson’s disease
9. Advent of New, More Effective and Personalized Medicines
10. Combing Hair More Effective Than OTC Medicine For Head Lice
11. Heart Patients Use Alternative Medicine
Post Your Comments:

(Date:11/26/2015)... ... November 26, 2015 , ... ... wellness consultation, has collaborated with Women’s Web – an online resource for ... topics on mental and emotional well-being relationship, life balance, stress, professional development, ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... potentially more aggressive than those found on mammography, according to a study published ... of additional cancers not seen on mammography may necessitate a change in treatment. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... preparing the perfect dish and pleasing the palates of attendees is of the ... a dish to a seasonal get-together, give these recipes a try this holiday ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, ... again for its stellar workplace culture with the company’s Cincinnati office being named ... Solutions’ Cincinnati office was named a finalist in Cincinnati Business Courier’s 13th annual ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Dr. John ... to learn more about hair loss treatment with the Capillus272™ Pro laser therapy cap. ... solution for thicker and fuller hair, without the need for surgery, prescription pills, or ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Monitoring (TDM) Market: Supplier Shares, Country ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: